Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.1M Buy
490,146
+103,655
+27% +$16.8M 0.61% 28
2025
Q4
$75.3M Buy
386,491
+218,251
+130% +$52M 0.69% 28
2025
Q3
$47.3M Sell
168,240
-34,375
-17% -$8.75M 0.45% 44
2025
Q2
$44.3M Sell
202,615
-3,787
-2% -$612K 0.5% 37
2025
Q1
$28.9M Sell
206,402
-15,102
-7% -$2.46M 0.42% 50
2024
Q4
$36.9M Buy
221,504
+98,524
+80% +$17.5M 0.65% 31
2024
Q3
$21M Buy
122,980
+89,142
+263% +$12.9M 0.53% 36
2024
Q2
$4.78M Buy
33,838
+1,554
+5% +$193K 0.13% 147
2024
Q1
$4.06M Buy
32,284
+1,758
+6% +$201K 0.08% 243
2023
Q4
$3.22M Buy
30,526
+3,139
+11% +$343K 0.08% 269
2023
Q3
$2.9M Buy
+27,387
New +$3.17M 0.09% 236

Other funds holding ORCL

Vident Advisory's ORCL Position: Q1 2026 in Review

Vident Advisory increased its Oracle (ORCL) stake by 27% in Q1 2026, buying an estimated $16.8M and bringing the position to 490,146 shares worth $72.1M. The position accounts for 0.61% of the portfolio, ranked #28.

Vident Advisory first reported a position in ORCL in Q3 2023 and has held it in 11 quarters since. The position peaked at $75.3M in Q4 2025. 3,472 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Vident Advisory held 490,146 shares of Oracle worth $72.1M as of Q1 2026.
  • Vident Advisory bought 103,655 Oracle shares in Q1 2026, an estimated $16.8M.
  • Oracle made up 0.61% of Vident Advisory's portfolio in Q1 2026, its #28 holding.
  • Vident Advisory first reported a position in Oracle in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Oracle position peaked at $75.3M in Q4 2025.
  • 3,472 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.